Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kangxinning granules for stable exertional angina (Qi deficiency and blood stasis)
CTR20140163Phase 2Completed
- Sponsor
- Inner Mongolia Autonomous Region Pharmaceutical Industry Research Institute
- Start
- Apr 2014
- Countries
- 1
01
Overview
A Phase 2 trial of Kangxinning granules in angina pectoris, coronary arteriosclerosis, sponsored by Inner Mongolia Autonomous Region Pharmaceutical Industry Research Institute. Started Apr 2014; status: completed.
02
Drugs
Kangxinning granules
03
Conditions
angina pectoriscoronary arteriosclerosis
Beyond the preview
Go deeper on CTR20140163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140163.